Pillstats
Rx only · Tablet, Film Coated · Oral

Ribociclib

Brands: Kisqali · Ribociclib Succinate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01EF02
RxCUI (US)1873916
US makers1 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$91.73$183.45$275.18$366.91Dec 2025May 2026Jul 2026
$318.332
Latest avg · Jul 22, 2026
-0%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.0K7.9K12K16K2025 Q12025 Q22025 Q32025 Q42026 Q1
14K
Rx · 2026 Q1
660K
Units dispensed
+48%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novartis Pharmaceuticals Corporationunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.